The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer

The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer

GATA2 is a pioneering transcription factor governing androgen receptor expression and signaling in prostate cells. To understand the prognostic potential of GATA2 assessment in prostate cancer, we analyzed nuclear GATA2 expression on an annotated tissue microarray with 12,427 prostate cancer samples...

Full description

Saved in:
Bibliographic Details
Main Authors: Franziska Büscheck, Maciej Zub, Asmus Heumann, Claudia Hube-Magg, Ronald Simon, Dagmar S Lang, Doris Höflmayer, Emily Neubauer, Frank Jacobsen, Andrea Hinsch, Andreas M Luebke, Maria Christina Tsourlakis, Guido Sauter, Hartwig Huland, Markus Graefen, Alexander Haese, Hans Heinzer, Torsten Schlomm, Till S Clauditz, Eike Burandt, Waldemar Wilczak, Stefan Steurer, Sarah Minner
Format: Article
Language:English
Published: SAGE Publishing 2019-07-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428318824815
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items